A detailed history of Gsa Capital Partners LLP transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 287,756 shares of KOD stock, worth $2.32 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
287,756
Holding current value
$2.32 Million
% of portfolio
0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$2.2 - $3.25 $633,063 - $935,207
287,756 New
287,756 $751,000
Q1 2024

May 03, 2024

BUY
$3.01 - $7.45 $78,783 - $194,996
26,174 New
26,174 $137,000
Q1 2023

May 12, 2023

SELL
$4.81 - $8.88 $580,759 - $1.07 Million
-120,740 Reduced 81.51%
27,397 $169,000
Q4 2022

Feb 13, 2023

BUY
$6.52 - $8.05 $38,663 - $47,736
5,930 Added 4.17%
148,137 $1.06 Million
Q3 2022

Nov 14, 2022

BUY
$7.57 - $12.5 $1.08 Million - $1.78 Million
142,207 New
142,207 $1.1 Million
Q2 2022

Aug 09, 2022

SELL
$5.04 - $9.48 $409,676 - $770,581
-81,285 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$7.09 - $89.45 $576,310 - $7.27 Million
81,285 New
81,285 $628,000
Q2 2021

Aug 05, 2021

SELL
$77.2 - $126.54 $186,901 - $306,353
-2,421 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$110.45 - $164.47 $22,863 - $34,045
-207 Reduced 7.88%
2,421 $275,000
Q4 2020

Feb 03, 2021

BUY
$60.78 - $154.03 $159,729 - $404,790
2,628 New
2,628 $386,000
Q2 2020

Aug 11, 2020

SELL
$42.74 - $66.25 $228,744 - $354,570
-5,352 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$38.18 - $73.95 $204,339 - $395,780
5,352 New
5,352 $255,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $419M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.